Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2012 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Other Working Capital Changes of -$202821.0 for Q1 2026, up 31.0% on a YoY basis from -$154825.6 in Q1 2025, and down 16.58% sequentially from -$173983.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 15 years of Other Working Capital Changes data on file, last reported at -$202821.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 31.0% year-over-year to -$202821.0; the trailing twelve-month figure through Mar 2026 stood at -$744979.0 (down 155.87% YoY), and the FY2025 full-year result was -$836100.0, down 146.86% from the prior year.
- Other Working Capital Changes fell to -$202821.0 in Q1 2026, from -$173983.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.7 million in Q4 2022 to a low of -$3.1 million in Q3 2022.
- A 5-year average of -$64492.9 and a median of -$239862.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 822.73% in 2022, while the deepest fall reached 482.06% in 2022.
- Tracing CPIX's Other Working Capital Changes over 5 years: stood at $2.9 million in 2022, then sank by 127.8% to -$804124.0 in 2023, then surged by 366.99% to $2.1 million in 2024, then slumped by 108.1% to -$173983.0 in 2025, then slipped by 16.58% to -$202821.0 in 2026.
- Business Quant data shows CPIX's Other Working Capital Changes at -$202821.0 in Q1 2026, -$173983.0 in Q4 2025, and -$221675.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -384,152.00 |
| Mar 31, 2026 | -384,152.00 |
| Mar 31, 2026 | -384,152.00 |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | -178,936.00 |
| Sep 30, 2025 | -178,936.00 |
| Sep 30, 2025 | -178,936.00 |
| Jun 30, 2025 | -579,652.00 |
| Jun 30, 2025 | -579,652.00 |
| Jun 30, 2025 | -579,652.00 |
| Mar 31, 2025 | -60,371.00 |
| Mar 31, 2025 | -60,371.00 |
| Mar 31, 2025 | -60,371.00 |
| Dec 31, 2024 | 833,606.00 |
| Dec 31, 2024 | 833,606.00 |
| Dec 31, 2024 | 833,606.00 |
| Sep 30, 2024 | -598,034.00 |
| Sep 30, 2024 | -598,034.00 |